Vantage Consulting Group Inc Amphastar Pharmaceuticals, Inc. Transaction History
Vantage Consulting Group Inc
- $9.74 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
263Shares Held
33.2MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$143 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$63.2 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.9 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$39.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.9 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.18B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...